Direct Answer
ResMed reported revenue of $5.1 billion for the fiscal year ended June 30, 2025, with an operating margin of 32.7% and net income of $1.4 billion, according to its SEC filings. Revenue grew 9.8% from the prior year.
What Are ResMed's Key Financial Figures?
| Fiscal year | FY2025 ended June 30, 2025 | FY2024 ended June 30, 2024 | FY2023 ended June 30, 2023 | FY2022 ended June 30, 2022 |
|---|---|---|---|---|
| Revenue | $5.1 billion | $4.7 billion | $4.2 billion | $3.6 billion |
| Operating income | $1.7 billion | $1.3 billion | $1.1 billion | $1.0 billion |
| Operating margin | 32.7% | 28.2% | 26.8% | 28.0% |
| Net income | $1.4 billion | $1.0 billion | $898 million | $779 million |
| Net margin | 27.2% | 21.8% | 21.3% | 21.8% |
| Operating cash flow | $1.8 billion | $1.4 billion | $693 million | $351 million |
| Capital expenditures | $90 million | $99 million | $120 million | $135 million |
| Free cash flow | $1.7 billion | $1.3 billion | $574 million | $216 million |
Operating margin widened by 4.6 percentage points between fiscal 2024 and 2025, which separates pricing and cost discipline from revenue growth alone. Free cash flow (operating cash flow minus capital expenditures) was $1.7 billion against net income of $1.4 billion; cash generation covered reported earnings.
What Does ResMed's Balance Sheet Show?
| Cash and cash equivalents | $1.2 billion |
|---|---|
| Long-term debt | $658 million |
| Total assets | $8.2 billion |
| Total liabilities | $2.2 billion |
| Shareholders' equity | $6.0 billion |
| Current ratio | 3.4x |
Balance sheet values are as of the end of fiscal 2025. Income statement figures describe a whole year; balance sheet figures describe a single day, so the two answer different questions.
Where These Numbers Come From
Every figure on this page is a value ResMed reported in its own SEC filings, read from the SEC's XBRL data (accession 0000943819-26-000047 for fiscal year 2025). Ratios are computed from those reported values. Figures were retrieved on October 7, 2026; a later amendment or a new annual report can change them, and the filing itself always takes precedence over this summary.
Each fiscal year is labeled by the calendar year in which it ended, so a company that names the same period differently in its own filings (many retailers whose year ends in January) may use another label. A year is left out of the table when the SEC data set holds no value for it. A figure shown as "Not reported" means the company did not file a value under the standard tag Swoopr reads, not that the amount was zero. This page is educational and describes reported history only; it is not a forecast or a recommendation.
Frequently Asked Questions
What was ResMed's revenue in fiscal 2025?
ResMed reported revenue of $5.1 billion for the fiscal year ended June 30, 2025, according to its SEC filings.
What is ResMed's operating margin?
ResMed's operating margin was 32.7% in fiscal 2025: operating income of $1.7 billion on revenue of $5.1 billion.
How much free cash flow did ResMed generate?
Operating cash flow of $1.8 billion less capital expenditures of $90 million gives free cash flow of $1.7 billion for fiscal 2025.